Abiopharma

🔍 Popeck Thomas C (Executive)

Company: HENRY SCHEIN INC (HSIC)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 53,206 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-03-06 | Code: A | equity_swap_involved: false | shares_owned_after: 88,124.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Grant of restricted stock units pursuant to the Issuer's 2024 Stock Incentive Plan. Subject to certain exceptions, (i) 50% will vest on the third anniversary of the grant date upon Issuer's ahievement of specified performance goals ("PSUs") and (ii) 50% will vest ratably on each of the first four anniversaries of the grant date ("RSUs"), in each case subject to continued service through the applicable vesting date. The payout for PSUs scale with performance, ranging from 0% to a maximum of 200%.